Sign In
Buy HIMS
$32.16
+1.34 (+4.35%)
At Close: Aug 04, 2026
Hims & Hers Health: Developing A Better Understanding
04:38pm, Thursday, 20'th Mar 2025
Hims & Hers Health has become one of the most popular growth stocks in the market today. After sharing with my readers a bullish perspective on the stock at ~$6/share in 2023, I'm back to provide a un
Jumping Into The FDA Gamble: Initiating Hims & Hers With A Buy
01:40pm, Thursday, 20'th Mar 2025
Hims & Hers Health, Inc. stock surged to $68, and the subsequent 50% crash is the talk of the town. I'm eyeing it as a favorable high-risk, high-reward play. HIMS stock plummeted after the FDA halted
Hims & Hers Has Superstar Potential, But It Will Take A Lot To Get There
11:35am, Thursday, 20'th Mar 2025
Hims & Hers (HIMS) is a newfangled tele-health company that started to ride the waves of GLP-1 weight loss medications. As waves go, this one's given the stock a heck of ride; way up and then all the
Why Hims & Hers Stock Tumbled on Tuesday
11:40am, Tuesday, 18'th Mar 2025
Hims & Hers Health (HIMS -6.95%) stock slid 7.4% through 11:10 a.m. ET Tuesday after Bank of America raised its price target on the pharmaceuticals stock in the worst way possible.
Why Hims & Hers Stock Popped on Monday
12:12pm, Monday, 17'th Mar 2025
Hims & Hers Health (HIMS 3.58%) stock jumped 2.2% through 10:45 a.m. ET Monday after Morgan Stanley analyst Craig Hettenbach delivered some good news for the mail-order drugs stock.
Defiance Launches RKLX and HIMZ: 2X Leveraged ETFs for Rocket Lab and Hims & Hers
01:00am, Thursday, 13'th Mar 2025
MIAMI, March 13, 2025 (GLOBE NEWSWIRE) -- Defiance ETFs introduces RKLX and HIMZ, two 2X leveraged single-stock ETFs designed to provide amplified exposure to Rocket Lab USA, Inc. (NASDAQ: RKLB) and H
Why the Market Dipped But Hims & Hers Health, Inc. (HIMS) Gained Today
06:50pm, Tuesday, 11'th Mar 2025
In the latest trading session, Hims & Hers Health, Inc. (HIMS) closed at $34.71, marking a +0.7% move from the previous day.
Why Hims & Hers Health Stock Just Popped
11:19am, Tuesday, 11'th Mar 2025
Roller-coaster healthcare stock Hims & Hers Health (HIMS 5.26%), whose stock got devastated last week by worries that it would be shut out of the GLP-1 market, got a reprieve from the Food and Drug Ad
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know
10:05am, Tuesday, 11'th Mar 2025
Hims & Hers Health (HIMS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Should You Buy Hims & Hers Stock on the Dip?
07:00am, Tuesday, 11'th Mar 2025
Hims & Hers (HIMS -4.12%) is taking investors on a roller-coaster ride in 2025.
Hims & Hers Stock Is Down 50% From Its High, but Is This a Buying Opportunity?
05:30am, Tuesday, 11'th Mar 2025
Hims & Hers (HIMS -4.12%) stock is down 50% from its peak earlier this year, but the drop in shares hasn't been driven by deteriorating operations. In fact, the company is growing as fast as ever.
3 Cold Stocks That Can Bounce Back This Week
10:15am, Monday, 10'th Mar 2025
This past week was rough for most investors, but it was a lot harder for a handful of cascading stocks. There were nearly a dozen U.S. exchange-listed companies with market caps north of $1 billion th
Bet on DuPont Analysis & Pick 5 Quality Stocks
07:36am, Monday, 10'th Mar 2025
Do you have more faith in DuPont analysis than simple ROE calculation? Tap Hims & Hers Health (HIMS), Blue Bird (BLBD), EMCOR Group (EME), EverQuote (EVER) and Sprouts Farmers Market (SFM).
Hims & Hers: AI-Powered Healthcare Disruption
12:38am, Sunday, 09'th Mar 2025
Hims & Hers generated $1.5 billion in revenue in 2024, reflecting a 69% year-over-year increase, and achieved $126 million in GAAP net income. The company's subscriber base reached 2.2 million, growin
Hims & Hers to shut down dermatology business Apostrophe
06:21pm, Friday, 07'th Mar 2025
Hims & Hers Health would discontinue Apostrophe, its personalized acne treatments dermatology business, the company said on Friday.
